DermwireTV 2024 Year in Review
Vtama Approved for AD in Adults and Children
Dermwire TV Extra: The Global Access to Skin Health Observatory
Esther Freeman, MD, PhD
Experts React to Latest Benzene Analysis
FDA Approves Bimzelx for Hidradenitis Suppurativa
DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
Emily Ruiz, MD, MPH
FDA Approves Rosacea Treatment Emrosi
DermWire TV Extra: Dr. Bunick on BPO Study
Christopher Bunick, MD, PhD, FAAD
DermWire TV Extra: Dr. Swanson on BPO
Lisa Swanson, MD, FAAD
FDA Approves Botox for Vertical Platysma Bands
New Analysis of Benzene Contamination in BPO Products
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
Melinda Gooderham, MSc, MD, FRCPC
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
NIH Analysis Examines Association Between AD and Comorbidities
DermWire TV Extra: SDPA President Amber Blair, PA-C, Previews Her New Column
Amber Blair, PA-C
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
Loading...
Stay current with the best on medical education
We're glad to see you're enjoying PracticalDermatology… but how about a more personalized experience?
Press cancel to remain on PracticalDermatology. Press the link below or the continue button to keep going.